These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14. Analysis of an oligonucleotide N3'-->P5' phosphoramidate/phosphorothioate chimera with capillary gel electrophoresis. DeDionisio LA; Raible AM; Nelson JS Electrophoresis; 1998 Nov; 19(16-17):2935-8. PubMed ID: 9870392 [TBL] [Abstract][Full Text] [Related]
15. Modified (PNA, 2'-O-methyl and phosphoramidate) anti-TAR antisense oligonucleotides as strong and specific inhibitors of in vitro HIV-1 reverse transcription. Boulmé F; Freund F; Moreau S; Nielsen PE; Gryaznov S; Toulmé JJ; Litvak S Nucleic Acids Res; 1998 Dec; 26(23):5492-500. PubMed ID: 9826777 [TBL] [Abstract][Full Text] [Related]
16. Antisense binding enhanced by tertiary interactions: binding of phosphorothioate and N3'-->P5' phosphoramidate hexanucleotides to the catalytic core of a group I ribozyme from the mammalian pathogen Pneumocystis carinii. Testa SM; Gryaznov SM; Turner DH Biochemistry; 1998 Jun; 37(26):9379-85. PubMed ID: 9649319 [TBL] [Abstract][Full Text] [Related]
17. Promotion of triplex formation by N3'-->P5' phosphoramidate modification: thermodynamic and kinetic studies. Torigoe H Nucleic Acids Res Suppl; 2001; (1):57-8. PubMed ID: 12836262 [TBL] [Abstract][Full Text] [Related]
20. Analysis of a ribonuclease H digestion of N3'-->P5' phosphoramidate-RNA duplexes by capillary gel electrophoresis. DeDionisio L; Gryaznov SM J Chromatogr B Biomed Appl; 1995 Jul; 669(1):125-31. PubMed ID: 7581876 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]